Opportunity
Texas DIR/ESBD #HHS0017209v2
Texas DSHS Requests Four Illumina MiSeq i100 Plus Sequencing Instruments
Posted
June 25, 2026
Respond By
July 09, 2026
Identifier
HHS0017209v2
NAICS
334516, 423490
The Texas Department of State Health Services (DSHS), part of the Texas Health and Human Services Commission (HHSC), is seeking bids for next generation sequencing instruments to support public health laboratory operations in Austin, TX. - Buyer: Texas Department of State Health Services (DSHS), under HHSC, Procurement and Contracting Services (PCS) - OEM Highlighted: Illumina - Products Requested: - Four (4) Illumina MiSeq i100 Plus sequencing instruments (part number 20115695 or MiSeq i100 Plus) - Each instrument must include: - Embedded touchscreen monitor - On-instrument computer - Control software - Hardware-accelerated Dragen Bio-IT secondary analysis pipelines - 12-month warranty (parts and labor) - No-cost replacement of reagents in case of instrument run failure - Capable of customer installation - Freight included as a lot - Strict brand/model requirement: Only Illumina MiSeq i100 Plus (part number 20115695) is specified; alternatives must include full technical literature for evaluation - Notable requirements: - 20% trade-in discount available for specified MiSeq system trade-ins - Delivery required within 14 days after receipt of order - No services or recurring support requested; this is a one-time purchase - Estimated historical spend for similar goods: ~$411,400 - All products must meet minimum technical specifications and warranty terms - Delivery location: DSHS Laboratory, Austin, Texas
Description
The Texas Department of State Health Services (DSHS) is soliciting bids for four MiSeq i100 Plus sequencing instruments from Illumina. These next generation sequencing instruments are used to sequence genetic material from clinical and environmental samples for surveillance, variant detection, outbreak detection, and identifying mutations of interest. Bidders offering alternatives to the specified brand must submit adequate literature with their bid to facilitate evaluation. All products must conform to the stated minimum specifications.